CFTR and cystic fibrosis: Notably, CF therapies over the past several decades have continued to improve, and the latest highly effective CFTR modulator therapies (HEMT) are changing the landscape of CF such that previously identified relationships between dysglycemia and pulmonary or nutritional outcomes may change.